Periprosthetic Fracture Registry (PPFx)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAO Innovation Translation Center
About this trial
This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty.
A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.
Eligibility criteria
Qualifiers
Age ≥18 years
Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring
osteosynthesis alone or
component revision plus plate/nail osteosynthesis
Disqualifiers
Pregnancy or women planning to conceive within the study period
Prisoner
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
13Belgium
Universitaire Ziekenhuiven Leuven Leuven Belgium
Colombia
Hospital Santa Clara Bogotá Colombia
Germany
Charité Universitätsmedizin Berlin Berlin Germany
BG-Unfallklinik Ludwigshafen Ludwigshafen Germany
Sponsors and collaborators
AO Innovation Translation Center
Lead sponsor
Source ClinicalTrials.gov